CAS 2271119-26-5

Fórmula: C20H20FN7O2

InChI: InChI=1S/C20H20FN7O2/c1-3-27-10-13-12(8-22)14(21)4-5-15(13)30-11(2)9-24-20(29)17-18(23)26-28-7-6-16(27)25-19(17)28/h4-7,11H,3,9-10H2,1-2H3,(H2,23,26)(H,24,29)/t11-/m0/s1

Chave InChI: UUDPUQDMSHQSKH-NSHDSACASA-N

SMILES: CCN1CC2=C(C=CC(=C2C#N)F)O[C@H](CNC(=O)C3=C4N=C1C=CN4N=C3N)C

CSF1R-IN-2

CAS: 2271119-26-5

CSF1R-IN-2 is an oral-active SRC, MET and c-FMS inhibitor (IC50s: 0.12 nM, 0.14 nM and 0.76 nM for SRC, MET and c-FMS respectively).

Fórmula: C₂₀H₂₀FN₇O₂

Pureza: 99.29%

Cor e Forma: Solid

Peso molecular: 409.42

Ref: TM-T13194

(S)-12-Amino-2-ethyl-45-fluoro-6-methyl-9-oxo-5-oxa-2,8-diaza-1(5,3)-pyrazolo[1,5-a]pyrimidina-4(1,2)-benzenacyclononaphane-46-carbonitrile

CAS: 2271119-26-5

Pureza: 99%

Ref: IN-DA01V4N5

CSF1R-IN-2

CAS: 2271119-26-5

CSF1R-IN-2

Fórmula: C₂₀H₂₀FN₇O₂

Pureza: ≥98%

Peso molecular: 409.42

Ref: 54-BUP08914

Elzovantinib

CAS: 2271119-26-5

(S)-12-Amino-2-ethyl-45-fluoro-6-methyl-9-oxo-5-oxa-2,8-diaza-1(5,3)-pyrazolo[1,5-a]pyrimidina-4(1,2)-benzenacyclononaphane-46-carbonitrile

Fórmula: C₂₀H₂₀FN₇O₂

Pureza: 99%

Peso molecular: 409.42

Ref: IN-DG01117669

CSF1R-IN-2

CAS: 2271119-26-5

CSF1R-IN-2 is a potent inhibitor of human tumor kinases that has been shown to have anticancer properties. It is a kinase inhibitor that targets the CSF1R protein, which is involved in cancer cell growth and survival. CSF1R-IN-2 has been found to induce apoptosis in cancer cells and inhibit tumor growth in animal models. This medicinal analog has been developed as a potential treatment for various types of cancer, including lung, breast, and pancreatic cancer. It is also being studied as a potential therapeutic agent for other diseases such as Alzheimer's disease and multiple sclerosis. CSF1R-IN-2 is excreted through urine and has shown promising results in Chinese clinical trials as an effective anticancer drug.

Fórmula: C₂₀H₂₀FN₇O₂

Pureza: Min. 95%

Peso molecular: 409.4 g/mol

Ref: 3D-WQD11926